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Registration of cancer in girls remains lower than expected
in countries with low/middle incomes and low female
education rates
SS Bhopal1,2, KD Mann2 and MS Pearce*,2
1Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK; 2Institute of Health and Society,
Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
BACKGROUND: A decade ago it was reported that childhood cancer incidence was higher in boys than girls in many countries,
particularly those with low gross domestic product (GDP) and high infant mortality rate. Research suggests that socio-economic and
cultural factors are likely to be responsible. This study aimed to investigate the association between cancer registration rate sex ratios
and economic, social and healthcare-related factors using recent data (1998–2002).
METHODS: For 62 countries, childhood (0–15 years) cancer registration rate sex ratios were calculated from Cancer Incidence in
Five Continents Vol IX, and economic, social and healthcare indicator data were collated.
RESULTS: Increased age standardised cancer registration rate sex ratio (M : F) was significantly associated with decreasing life expectancy
(P¼ 0.05), physician density (P¼ 0.05), per capita health expenditure (P¼ 0.05), GDP (P¼ 0.01), education sex ratios (primary
school enrolment sex ratio (Po0.01); secondary school enrolment sex ratio (Po0.01); adult literacy sex ratio (Po0.01)) and
increasing proportion living on less than Int$1 per day (P¼ 0.03).
CONCLUSION: The previously described cancer registration sex disparity remains, particularly, in countries with poor health system
indicators and low female education rates. We suggest that girls with cancer continue to go undiagnosed and that incidence data,
particularly in low- and middle-income countries, should continue to be interpreted with caution.
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With 86% of the world’s children living in low- and middle-income
countries (LIC, MIC), worldwide inequities in child health and
access to healthcare are well documented. In 2009, one in eight
children in Sub-Saharan Africa did not reach their fifth birthday,
compared to fewer than one in 150 in North America (United
Nations, 2010). Within this worldwide inequality, there are
significant differences within countries, for example, between
rural and urban dwellers, and between children of rich and poor
families. However, another key factor is a child’s sex – a girl in
India being 40% more likely to die between the ages of one and
five years old than a boy (Claeson et al, 2000). Explanations for
sex-based health differences come from biological, socio-cultural
and environmental reasons (Victora et al, 2003). In Punjab (India)
and Matlab (Bangladesh), boys are breastfed for longer and given
more food after weaning (Elliot and Sorsby, 1979). It has been said
that girls receive less and poorer quality healthcare, with studies
reporting less money spent on healthcare for girls during the early
years of life (Gupta, 1987).
Sex variation in childhood cancer incidence has been noted
for some time. These differences are seen most clearly in the
haematological malignancies in Europe (Parkes et al, 1994;
Cartwright et al, 2002), Asia (Nandakumar et al, 1996; Siddiqui
et al, 2006) and Africa (Welbeck and Hesse, 1998; Haroun et al,
2006), where Hodgkin’s lymphoma, in particular, has been found
to be more prevalent in boys, with a considerably greater M : F
ratio in developing countries (Dinand and Arya, 2006). Calls have
been made to analyse girls and boys rates separately (Birch and
Blair, 1992; Pramanik et al, 1997) in order to best understand
disease patterns, trends and aetiology (Welbeck and Hesse, 1998;
Khan et al, 1997; Magnanti et al, 2008).
Global compilations of population-based cancer registries
provide an opportunity to explore sex differences in cancer
incidence comprehensively. Pearce and Parker (2001) used an
International Agency for Research on Cancer (IARC) report
(Parkin et al, 1998) to explore 1980’s data, finding high registration
sex ratios to be associated with decreasing gross domestic product
(GDP) and increasing infant mortality rate (IMR) (Pearce and
Parker, 2001). This suggested that cancer registration rates in girls
were not as high as would be expected in a number of developing
countries.
This study used more recent (1998–2002) IARC data (published
in Cancer Incidence in Five Continents, Volume IX (CI5 IX;
Curado et al, 2007)) and a wider range of national level health,
social and economic data to investigate further the associations
between cancer registration sex ratios and economic, social and
healthcare-related factors – and in particular to examine whether
the previously described findings persist.
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MATERIALS AND METHODS
Cancer Incidence in Five Continents reports data from 1998 to
2002 from 225 cancer registries (5 from Africa; 11 South and
Central America; 54 North America; 44 Asia; 100 Europe; and 11
Oceania) detailing cancer cases and incidence rates according to
sex, age group and cancer site coded by ICD-10 classification. A
total of 182 registries presented independent data. For five
countries, where both regional and combined-regional data were
presented, only the combined data were used in this analysis. Cases
and population data for registries based within the same country
were combined, creating a total of 62 data points (5 from Africa, 7
South and Central America, 12 North America, 16 Asia, 29 Europe
29 and 3 Oceania 3).
Cancer case numbers and age-standardised incidence rates for
all cancers and lymphomas were retrieved from CI5 IX. Age-
standardised incidence rates were calculated using the method
outlined in CI5 IX Chapter 7 (Boniol and Heanue, 2007), taking
into account different person-years at risk for countries whose
combined registries spanned different time periods.
Sex-specific childhood (under 15 years) population data were
retrieved from age-specific tables published in CI5 IX. Cancer-
reporting regulation data (whether cancer is reportable by
legislation, by administrative order without specific law; not
reportable or mixed) were collected from within CI5 IX
methodological tables.
National level economic (per capita GDP; proportion living on
less than Int$1 per day), social (primary and secondary school
enrolment sex ratios – defined as the ratio of the number of female
students enrolled in such schools (both public and private) – to the
number of male students), adult literacy ratio (females :males) and
healthcare (average life expectancy; physician density per 10 000
population; per capita healthcare expenditure and the infant
(i.e. 0–1 year) mortality rate per 1000 live births) data were
compiled using the UNData web-portal (United Nations Statistics
Division, online) for 1998–2002 from primary sources, including
the United Nations Statistics Division, the United Nations
Children’s Fund, the World Health Organisation and the UNESCO
Institute for Statistics.
Statistical analysis
Cancer case sex ratios (male : female) and age-standardised cancer
rate sex ratios (accounting for underlying M : F population
differences) were calculated for all cancers; Hodgkin’s lymphoma
(HL), non-Hodgkin’s lymphoma (NHL) and ‘non-lymphoma
cancer’ designated as those excluding HL and NHL. Explanatory
variables, detailed above, were defined on continuous scales except
for ‘cancer reporting regulation’, which was treated as categorical.
Relationships between the dependent variables (the cancer rate sex
ratios) and explanatory variables were estimated by linear
regression, with fractional polynomials used where evidence
existed for non-linear associations (Royston et al, 1999).
F-tests were used to assess associations between the dependent
variable and continuous explanatory variables. The Kruskal–Wallis
test was used to assess associations between the dependent
variables and the categorical variable, cancer-reporting regulation.
The statistical software package Stata, version 10 (StataCorp.,
College Station, TX, USA) was used for all analyses.
RESULTS
Significant correlations were seen between most of the explanatory
variables included in this study (Table 1, where correlations with
Po0.05 are denoted by asterisk (*)). There was a large range of
age-standardised cancer rate sex ratios (from 0.66 in Thailand to
1.84 in Bahrain; Table 2). Excluding lymphomas, the range was
similarly wide (from 0.61 in Thailand to 1.82 Bahrain).
The majority of countries had an age-standardised cancer rate
sex ratio of less than 1.4 (Table 2), with nine countries ratio being
greater than this (China 1.42; Singapore 1.46; Egypt 1.48; Uganda
1.49; India 1.57; Pakistan 1.58; Zimbabwe 1.60; Chile 1.71; Bahrain
1.84). Excluding lymphomas, again, most countries had an age-
standardised cancer rate sex ratio less than 1.4 with six countries
having a rate ratio greater than this (India 1.45; Zimbabwe 1.47;
Pakistan 1.48; Uganda 1.54; Chile 1.56; Bahrain 1.82). A number of
countries had age-standardised cancer rate ratios of less than one
(Argentina 0.97; Poland 0.97; Oman 0.96; Cyprus 0.91; Lithuania
0.89; Thailand 0.66). All of these had wide confidence intervals,
with only the interval for Thailand excluding 1 (Table 2).
Significant associations were found between a number of
explanatory variables and the age-standardised cancer rate sex
ratios (Table 3). Increasing cancer rate sex ratio was significantly
associated with increasing proportion of those living on less than
Int$1 per day (Po0.02), decreasing GDP (Po0.01), healthcare
variables including decreasing life expectancy (P¼ 0.03), decreas-
ing physician density (P¼ 0.05), decreasing per capita health
expenditure (P¼ 0.01) and increasing IMR (Po0.01). Increasing
cancer rate sex ratios were also significantly associated with socio-
cultural variables including both education sex ratios (primary
Po0.01, secondary Po0.01) and decreasing F :M adult literacy
ratio (Po0.01). There was no significant association between
reporting regulations and cancer rate sex ratio (P¼ 0.266).
All of these associations persisted when lymphomas were
excluded. Adjustment to account for differences in registry size
had little effect on the reported associations. Multiple regression
models yielded uninterpretable results due to multi-colinearity of
the independent variables.
Table 1 Correlation (r) between the independent variables included in this study
GDP
per capita
(PPP
Int $)
IMR
(0–1 year)
per 1000
live
births
o1
PPP
Int $
per
day (%)
Life
expectancy
at birth
(years)
Per capital
total
expenditure
on health
(PPP Int $)
Physician
density
(per 10 000
population)
Primary
school
enrolment
ratio
F :M
Secondary
school
enrolment
ratio
F :M
Adult
literacy
ratio
GDP per capita (PPP Int $) 1.00
IMR (0–1 year) per 1000 live births  0.53* 1.00
o1 Int $ per day  0.43* 0.87* 1.00
Life expectancy at birth (years) 0.62*  0.88*  0.77* 1.00
Per capital total expenditure on
health (PPP int $)
0.91*  0.55*  0.45* 0.64* 1.00
Physician density (per 10 000
population)
0.44*  0.67*  0.59* 0.63* 0.53* 1.00
Primary school enrolment ratio F : M 0.36*  0.74*  0.55* 0.55* 0.37* 0.40* 1.00
Secondary enrolment ratio 0.22  0.77*  0.65* 0.63* 0.24 0.42* 0.77* 1.00
Adult literacy ratio 0.38*  0.81*  0.63* 0.59* 0.44* 0.52* 0.87* 0.79* 1.00
Abbreviations: GDP¼ gross domestic product; IMR¼ infant mortality rate; PPP Int $P¼ purchasing power parity international dollars.
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From calculated R2 values in the univariate models, the most
important predictor of all cancer rate sex ratio was adult literacy
sex ratio (accounting for 17% of the variation) and IMR
(accounting for 18%) (Table 3).
DISCUSSION
We found that rates of cancer registrations in girls remain lower
than expected in LIC and MIC, even when lymphomas were
Table 2 Global Childhood cancer, economic, healthcare and social data for the 62 countries included in this study
Population
All
cancer
cases
M : F
All
cancera
rate sex
ratio
0–14
(M :F)
(95% CI)
Non-
lymphoma
cancera
rate sex
ratio
0–14 (M : F)
(95% CI)
GDP
per
capita
(PPP
Int $)
IMR
(0–1
year)
per
1000
live
births
o1
PPP
Int$/
day
(%)
Life
expectancy
at birth
(years)
Per
capital
total
expenditure
on health
(PPP Int $)
Physician
density
(per 10 000
population)
Primary
school
enrolment
ratio F :M
Secondary
school
enrolment
ratio F :M
Adult
literacy
ratio
Algeria 113 : 90 1.29 (1.01, 1.57) 1.10 (0.79, 1.40) 1796 41 7 70 188 11 0.92 1.04 0.79
Argentina 30 : 28 0.97 (0.46, 1.49) 0.94 (0.40, 1.48) 7698 19 5 74 814 30 0.98 1.07 1.00
Australia 1513 : 1256 1.15 (1.07, 1.22) 1.08 (1.00, 1.15) 20 845 5 0 80 2271 25 1.00 1.02 1.00
Austria 548 : 406 1.28 (1.15, 1.41) 1.22 (1.08, 1.36) 23 886 5 0 78 2858 37 0.99 0.96 1.00
Bahrain 49 : 26 1.84 (1.36, 2.31) 1.82 (1.31, 2.32) 12 350 11 0 73 820 27 1.02 1.08 0.96
Belarus 623 : 516 1.18 (1.06, 1.30) 1.05 (0.92, 1.18) 1036 15 2 69 328 48 0.99 1.04 1.00
Belgium 368 : 314 1.12 (0.97, 1.27) 0.98 (0.82, 1.15) 22 754 5 0 78 2519 42 0.99 1.02 1.00
Brazil 1682 : 1389 1.18 (1.11, 1.25) 1.08 (1.01, 1.16) 3702 28 5 70 506 12 0.94 1.08 1.01
Bulgaria 390 : 301 1.30 (1.14, 1.45) 1.19 (1.02, 1.35) 1574 14 2 72 377 37 0.98 0.98 0.99
Canada 1736 : 1420 1.17 (1.10, 1.24) 1.11 (1.04, 1.18) 23 623 5 0 79 2514 19 1.00 1.02 1.00
Chile 48 : 29 1.71 (1.25, 2.17) 1.56 (1.07, 2.04) 4877 9 2 77 572 11 0.98 1.02 1.00
China, Hong
Kong
401 : 281 1.31 (1.16, 1.46) 1.21 (1.05, 1.37) 25 368 NA NA 81 NA NA 0.96 NA NA
China 546 : 411 1.42 (1.29, 1.55) 1.36 (1.23, 1.50) 958 30 16 71 109 14 1.03 1.05 0.93
Colombia 220 : 179 1.20 (1.00, 1.40) 1.09 (0.88, 1.30) 2365 21 16 72 370 14 1.00 1.10 1.00
Costa Rica 407 : 362 1.08 (0.94, 1.22) 1.02 (0.87, 1.17) 4057 12 2 77 467 13 0.98 1.09 1.01
Croatia 376 : 287 1.28 (1.13, 1.44) 1.22 (1.06, 1.39) 4738 7 2 74 839 25 0.99 1.02 0.98
Cyprus 65 : 67 0.91 (0.57, 1.26) 0.89 (0.52, 1.26) 13 399 5 0 77 1973 23 1.00 1.03 0.98
Czech
Republic
497 : 355 1.34 (1.21, 1.48) 1.19 (1.04, 1.34) 5547 4 2 75 980 36 0.99 1.02 1.00
Denmark 352 : 293 1.16 (1.00, 1.31) 1.08 (0.91, 1.24) 30 004 5 0 77 2379 36 1.00 1.03 1.00
Ecuador 167 : 141 1.16 (0.94, 1.39) 1.09 (0.85, 1.34) 1294 28 5 70 202 15 0.99 1.03 0.98
Egypt 370 : 238 1.48 (1.32, 1.65) 1.16 (0.97, 1.35) 1419 38 2 67 208 24 0.92 0.95 0.73
Estonia 77 : 74 1.02 (0.71, 1.34) 1.00 (0.65, 1.35) 4107 9 2 71 521 33 0.97 1.05 1.00
Finland 375 : 325 1.11 (0.96, 1.25) 1.07 (0.92, 1.23) 23 543 4 0 78 1794 33 0.99 1.02 1.00
France 575 : 444 1.23 (1.11, 1.36) 1.15 (1.01, 1.28) 21 830 4 0 79 2542 34 0.99 1.02 1.00
French
Polynesia
29 : 23 1.21 (0.66, 1.76) 1.25 (0.67, 1.83) 10 363 10 NA 57 NA NA NA NA 1.00
Germany 827 : 677 1.18 (1.08, 1.28) 1.13 (1.02, 1.24) 23 152 4 0 78 2670 34 0.99 0.99 1.00
Iceland 19 : 17 1.08 (0.43, 1.74) 0.98 (0.31, 1.65) 30 942 3 0 80 2738 38 0.98 1.06 1.00
India 3152 : 1813 1.58 (1.52, 1.63) 1.45 (1.39, 1.51) 449 68 42 61 63 6 0.84 0.71 0.71
Ireland 302 : 250 1.15 (0.98, 1.32) 1.08 (0.90, 1.26) 25 394 6 0 76 1950 29 0.99 1.06 1.00
Israel 698 : 523 1.27 (1.16, 1.38) 1.18 (1.05, 1.30) 20 503 6 NA 80 1845 NA 0.99 1.02 NA
Italy 984 : 756 1.22 (1.12, 1.31) 1.16 (1.06, 1.26) 19 213 5 0 79 2061 37 1.00 1.01 0.99
Japan 762 : 565 1.28 (1.17, 1.39) 1.25 (1.14, 1.36) 36 837 3 0 81 1967 21 1.00 1.01 1.00
Korea
(Republic of)
2581 : 2018 1.16 (1.10, 1.21) 1.12 (1.06, 1.18) 11 488 42 2 67 747 1 0.99 0.99 1.00
Kuwait 211 : 152 1.29 (1.08, 1.50) 1.17 (0.94, 1.40) 16 926 10 0 76 903 18 1.02 1.02 0.97
Latvia 182 : 132 1.15 (0.92, 1.37) 1.09 (0.85, 1.33) 3300 12 0 71 456 31 0.98 1.03 1.00
Lithuania 200 : 217 0.89 (0.70, 1.08) 0.87 (0.66, 1.07) 3266 8 2 72 543 40 0.99 1.01 1.00
Malaysia 337 : 260 1.23 (1.07, 1.39) 1.21 (1.04, 1.38) 4030 9 2 71 289 7 1.00 1.09 0.95
Malta 36 : 26 1.33 (0.82, 1.83) 1.25 (0.72, 1.79) 10 010 6 0 78 2864 39 1.01 1.01 1.04
New Zealand 369 : 261 1.34 (1.19, 1.50) 1.33 (1.16, 1.49) 13 613 6 0 79 1686 21 1.00 1.03 1.00
Norway 317 : 256 1.18 (1.02, 1.35) 1.12 (0.94, 1.29) 37 531 4 0 79 3039 38 1.00 1.01 1.00
Oman 164 : 169 0.96 (0.74, 1.17) 0.90 (0.66, 1.14) 8097 13 0 73 461 17 0.97 1.02 0.87
Pakistan 223 : 131 1.58 (1.36, 1.79) 1.48 (1.24, 1.72) 530 85 23 62 40 8 0.68 0.70 0.59
Peru 49 : 38 1.25 (0.83, 1.68) 1.27 (0.83, 1.71) 2051 36 8 72 232 12 0.99 0.97 0.90
Philippines 523 : 439 1.14 (1.01, 1.27) 1.11 (0.98, 1.24) 977 28 23 70 80 12 1.00 1.18 1.01
Poland 169 : 163 0.97 (0.75, 1.18) 0.86 (0.62, 1.09) 4456 8 2 74 583 20 0.99 1.04 0.99
Portugal 380 : 325 1.11 (0.96, 1.26) 1.01 (0.84, 1.17) 11 016 5 0 77 1509 34 0.96 1.08 0.97
Russia 239 : 191 1.19 (1.00, 1.38) 1.06 (0.86, 1.27) 1771 20 2 65 410 43 0.99 NA 1.00
Serbia 330 : 249 1.25 (1.08, 1.41) 1.17 (1.00, 1.35) 1161 11 0 72 411 20 0.99 1.02 1.00
Singapore 249 : 161 1.46 (1.27, 1.66) 1.38 (1.17, 1.59) 23 073 3 0 78 1151 15 NA NA 0.94
Slovakia 351 : 304 1.11 (0.96, 1.26) 1.11 (0.95, 1.28) 3791 8 2 73 603 31 0.99 1.02 1.00
Slovenia 122 : 97 1.25 (0.98, 1.52) 1.15 (0.86, 1.44) 10 018 5 2 76 1447 24 1.02 1.04 1.00
Spain 506 : 422 1.13 (1.00, 1.26) 1.04 (0.90, 1.18) 14 422 4 0 79 1536 33 0.99 1.03 0.98
Sweden 584 : 496 1.09 (0.97, 1.21) 1.03 (0.90, 1.16) 27 716 3 0 80 2283 33 1.03 1.04 1.00
Switzerland 183 : 136 1.29 (1.07, 1.52) 1.22 (0.98, 1.45) 34 787 5 0 80 3265 40 1.00 0.94 1.00
Thailand 211 : 206 0.66 (0.47, 0.85) 0.61 (0.40, 0.81) 1968 17 2 68 172 4 0.98 0.97 0.97
The
Netherlands
1169 : 827 1.34 (1.25, 1.43) 1.25 (1.16, 1.35) 24 196 5 0 78 2337 37 0.98 1.00 1.00
Tunisia 50 : 36 1.32 (0.89, 1.74) 1.24 (0.77, 1.72) 2057 23 3 73 271 13 0.95 1.07 0.80
Turkey 399 : 320 1.22 (1.07, 1.37) 1.11 (0.95, 1.27) 4011 36 3 70 432 16 0.92 0.80 0.84
United
Kingdom
3297 : 2646 1.19 (1.14, 1.24) 1.12 (1.07, 1.17) 25 082 6 0 78 1846 23 1.00 1.01 1.00
USA 19253 : 16134 1.14 (1.12, 1.16) 1.10 (1.07, 1.12) 33 924 7 0 77 4570 26 0.98 1.02 1
Uganda 239 : 175 1.49 (1.30, 1.69) 1.54 (1.29, 1.78) 260 98 52 46 45 1 0.94 0.86 0.8
Zimbabwe 195 : 135 1.60 (1.38, 1.82) 1.47 (1.23, 1.70) 452 62 0 44 1 2 0.97 0.90 0.94
Abbreviations: GDP¼ gross domestic product; IMR¼ infant mortality rate; NA¼ not available; PPP Int $¼ purchasing power parity international dollars. Dark highlight¼ top
nine cancer rate sex ratios (41.4); Light highlight¼ cancer rate sex ratio o1. aAge standardised.
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excluded from analysis. The strongest association was with adult
literacy sex ratio, suggesting a strong persisting influence of social
indicators, but also with economic, healthcare and other social
indicators.
Our study has several fundamental strengths. We used high
quality validated data from CI5 IX, with in-built quality controls
including a check on abrupt changes in cancer cases and rates year
by year – both measures of completeness (Ferley, 2007). Using
exclusively population-based registries allowed for the most
accurate record held to be explored in these data. Both case and
age standardised rate sex ratios were calculated. The case sex ratio
was generally larger than the rate ratio for a country. However,
associations
with variables were similar. The calculation of rate sex ratios is an
improvement compared with previous methods of using case
ratios, which assumed a M : F population ratio of close to one.
Using CI5 IX data allowed for analysis by cancer type and age.
Crucially it allowed the calculation of a ‘non-lymphoma cancer’
rate ratio, showing that the known higher male incidence of HL
and NHL is not the sole reason for our finding of a raised
incidence of reported cancer in boys.
Accuracy of rate ratios calculation relies on accuracy of
population data. These data are usually outwith the control of
cancer registry officials, and particularly in LIC and MIC may be
subject to rapid shifts owing to, for example, migration, refugees or
rapid changes in birth and death rates (Howard et al, 2008).
There is a some variation in registration methods between
registries as noted in Chapter 5 in CI5 IX (Shin et al, 2007). Some
countries require reporting of cancer through legislation, while in
others cancer is not a reportable disease. Case-finding methods
vary considerably, with some registries including only public
hospitals and not covering private hospital and clinics. Some use
autopsy reports, death certificates and screening programmes
while others do not. It has been reported that the experienced
cancer registries record much higher incidence of childhood
cancer (Swaminathan et al, 2008), suggesting that case-finding can
be improved. However, we found little evidence that reporting
legislation had an effect on our findings. Additionally, it is clear
that CI5 IX editors made considerable efforts to enhance
comparability, stating that their aim ‘is to present comparable
incidence rates of cancer from different populations worldwide’.
This is done through attention to definition of incidence, multiple
primaries, incidental and autopsy diagnosis, and coding practice.
Completeness was checked using a variety of methods wherever
possible including comparison with historic data, proportion of
cases microscopically diagnosed, proportion of unknown basis of
diagnosis, mortality : incidence (M : I) ratio and death certificate
method. Importantly, the editors use this information to decide
which of the submitted data are of high enough quality to include
in the final report.
The use of national level economic, social and healthcare data
gave an indication as to the likely local reality in an area covered
by a regional registry. However, these data cannot account
for within-country variations, rural/urban differences being of
particular note, and in some countries, the registries have an urban
population focus. Ideally, these economic, social and healthcare
data would be collected from the exact cancer registry population,
but this is often not possible. Additionally, these data have in-built
errors, often due to poor reporting and data collection methods.
For example, vital registration data on mortality rates is
notoriously poor (Mathers et al, 2005), particularly in LIC and
MIC.
A number of countries that were considered in Pearce and
Parker’s (2001) previous paper were not included within our data
set as they were not included in CI5 IX. A number of cancer
registries were not accepted by IARC for publication in CI5 IX due
to quality control reasons. Similarly, presented data are available
in the literature and online (Banda et al, 2001); however, those
have not been subject to CI5 IX quality controls, so were excluded
from our analysis.
We cannot comment on whether the true incidence of cancer is
smaller overall in girls compared with boys, rather we found that
girls are being registered less than boys. Girls with cancer may
also be under-diagnosed compared with boys. There remains a
question over why girls are missed. Howard et al (2008) described
the ‘links in the chain of childhood cancer diagnosis and
registration’, pointing to the multiple steps needed for a child
with cancer to be registered. First, an unwell child must be
recognised as such by family or community, they then must access
primary care, be diagnosed, referred and reach a tertiary referral
centre, have a thorough histological diagnosis of cancer in a
laboratory and finally be registered in a database. There are
multiple risks and barriers at and between each of these steps,
including poor parental awareness, lack of transportation, poorly
qualified healthcare staff, lack of laboratory and diagnostic
equipment, lack of money to pay for treatment and so on. The
population-based registries that contributed to CI5 IX aim to
overcome this problem through a variety of case-finding methods
including hospital in-patient records, radiotherapy departments,
public and private hospitals, their in- and out-patient facilities,
pathology laboratories, autopsies, haematology laboratories, death
certificates, and screening programmes.
Our findings fit with previous data describing that sick girls
tend not to be taken for healthcare as much or as early as boys
(Gupta, 1987; Hossain and Glass, 1988; Sauerborn et al, 1996; Kurz
and Johnson-Welch, 1997; Swaminathan et al, 2008), suggesting
that this may be a break in the chain. Of particular interest is that
while indicators, including GDP and IMR, have improved
considerably since Pearce and Parker’s previous paper, the
previously described association remains. This is somewhat
expected finding, in that we would not expect an improvement
in GDP (a weak indicator of individual and community wealth) to
lead directly to improvement in cancer services, particularly over
just one decade. In addition, improved overall child survival
figures are likely to have emerged from improvements in other
conditions.
The main current explanation suggests that that there is a
sex-biased inequity related to inferior status of the girl child in
Table 3 Results of unadjusted regression models between age standardised all cancer rate sex ratio and independent variables
Variable Co-efficient 95% CI P R2
GDP per capita (PPP Int $)  0.01 0.00, 0.02 0.002 0.15
IMR (0–1 year) per 1000 live births 0.01 0.00, 0.01 0.001 0.18
o1 PPP Int$/day (%) 0.01 0.00, 0.01 0.015 0.10
Life expectancy at birth (years)  0.01  0.01, 0.00 0.027 0.08
Per capital total expenditure on health (PPP Int $)a  0.04  0.08,  0.01 0.013 0.10
Physician density (per 10 000 population)b  -0.11  0.22, 0.01 0.050 0.06
Primary school enrolment ratio F : M 0.88 0.16, 1.60 0.017 0.09
Secondary school enrolment ratio F : M 0.75 0.27, 1.24 0.003 0.15
Adult literacy ratio F : M  0.95  1.50,  0.40 0.001 0.17
Abbreviations: GDP¼ gross domestic product; IMR¼ infant mortality rate; PPP Int $¼ purchasing power parity international dollars. aLog transformation. bSquare root
transformation.
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developing countries (Chen et al, 1981). Indeed, this explanation is
often alluded to by authors studying childhood cancer incidence
(Yaris et al, 2004; Agboola et al, 2009) with still little empirical
evidence available. Our finding that those countries with poorer
markers of female education are more likely to have missing girls
would appear to support this hypothesis. It may be that when
resources are limited, culture and economics favour boys.
Further research is required to explore our hypotheses,
particularly whether culture and economics favour boys, and at
which point in the ‘chain’ of cancer registration girls are being
missed. While there remains a debate over whether child cancer
care in general is a useful healthcare priority (Markman, 2005),
other research is tied to a general sex equity agenda, for example,
by finding ways of encouraging families to seek care for their girls
and improving healthcare service design to increase accessibility to
all.
Most children live in LIC and MIC; however, the majority of
cancer registries are based in high-income countries. Recent
initiatives have focussed on twinning of experienced paediatric
oncology units to cross this divide (Masera et al, 1993; Masera
et al, 1998; Cole, 2004), both in clinical management of
children and in supporting data collection and cancer registry
formation and continuation. These data are needed to add further
evidence to our findings and to explore further the reasons
behind them.
CONCLUSION
Our findings suggest that the previously described cancer
registration sex disparity remains, particularly in countries with
poor health system indicators and low female education rates.
We suggest that girls with cancer continue to go undiagnosed and
that incidence data – particularly in LIC and MIC – should
continue to be interpreted with caution.
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